CANCER –  2019

 Dates: April 25, 2019


 Main topics:

This meeting will serve as a valuable forum for the presentation
and discussion of newly available data across various
 malignancies including all cancers.
 Participants will be provided with updates on practice-changing data
 in a practical and interactive format, fostering discussion,
 and impacting clinical outcomes for patients.

 

Programme:

 

Day 1 – Optimising Clinical Development in Oncology

    • Targeted therapies in clinical development; antibody, vaccines & cell-based therapies

 

  • Overcoming the mechanisms of cancer drug resistance

 

 

  • Co-development of combined oncology therapies

 

 

  • Identifying appropriate clinical endpoints

 

 

  • Strategies to reach critical go/no-go decisions earlier

 

 

  • Novel technologies for imaging in drug development

 

 

  • Pharmacovigilance & patient safety

 

 

  • Integrating biomarkers in clinical development & trials

 

 

Day 2 – Operational Challenges of Oncology Clinical Trials

    • Establishing the correct trial population; emerging markets, global  trials

 

  • Adaptive clinical trial design

 

 

  • Appropriate site selection

 

 

  • Regulatory considerations

 

 

  • Clinical trial management

 

 

  • Patient recruitment and retention strategies

 

 

  • Successfully maintaining CRO relationships

 

 

  • Effective use of clinical data & eClinical solutions

 

 

 

Call for abstracts

Deadline for submission: 10/09/2018

The late abstract should contain newly achieved scientific work and results. The abstract has to be one full page (size A4, 210 x 297 mm) plus 1 to 3 explanatory pages with more detailed information about the work.
The abstract written in English and single spaced should include:

  • Applicable topic
  • Full title
  • Full name, affiliation, address, phone/fax/e-mail of one author for all correspondence
  • For all other co-authors, full name, affiliation and e-mail
  • Short introductive summary (approx. 1,000 characters) for publication in the   Programme Planner
  • Purpose of the work
  • Approach
  • Scientific innovation and relevance
  • Results and Conclusions

 

For questions concerning abstracts, please contact:

Ms. Kristina Zadorinaemail uk@nbscience.com

The attendees of this event will get a chance to take part in:

  • master class on modern instrumental methods of diagnostics of rheumatic diseases- ultrasounds, MRI, osseo densitometry.
  • master class on increasing effective drug treatment of patients with rheumatic diseases.

 

 Conditions of participation for participants:

 

Registration Package   includes   certificate of participation (English language) ,participation in scientific sessions, conference materialsvisit to the exhibition and 10-30% discount for accomodation in hotel.

 

 

 

Online registration is required.No admission without registration confirmation.

 

nbscience

(deadline – November 01, 2018)

 

 

Contact NBScience’s

Education/Conference Department:

conference@nbscience.com

pharmacology

stem cell therapy